Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» N!006
N!006
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy